Clinical trial · Interventional
Use of a Virtual Reality Cognitive Stimulation Programme for Breast Cancer Patients Wishing to Restart or Maintain a Professional Activity
NCT06267014CI-TRIAL-00102926Cog-RVcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study concerns patients who have been treated for breast cancer, have cognitive problems and are planning to return to work or are currently working and wish to begin cognitive rehabilitation. Patients will follow the Virtual Reality program developed for the study, during the cognitive rehabilitation usually proposed in the establishment, at the rate of a weekly session of 10-15 minute for 6 weeks.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Cancer-related Cognitive Difficulties | Breast Neoplasm | PROBABILISTIC | 0.70 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Virtual Reality sessions | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Virtual Reality sessions
- interventionNames
- Behavioral: Virtual Reality sessions
Primary outcomes (1)
- measure
- Proportion of patients adhering to the Virtual Reality program
- timeFrame
- At 6 weeks
- description
- Adherence is defined as the completion of at least 5 of the 6 sessions planned.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients \>18 years of age * Patient with breast cancer for whom adjuvant chemotherapy has been administered; maintenance treatments (e.g. Trastuzumab, hormone therapy) are eligible, * Maximum 2 years after completion of adjuvant treatment, * Patients who have cognitive complaints at inclusion (answer yes to the question: 'Since your cancer treatment, have you had any difficulties with memory, concentration, etc.?) * Patients planning to return to work or who have returned to work in the past year, * Signature of informed consent prior to any specific procedure relating to the study, * Patient affiliated to a social security system. Exclusion Criteria: * Patients suffering from illnesses or conditions that impair their ability to understand, follow and/or comply with study procedures, * Patients with personality disorders and/or psychiatric pathology, * Patients deprived of their liberty or placed under the authority of a guardian, * Pregnant women
References
Publications (1)
- DERIVEDVieira Jales I, Hummel E, Clarisse B, Gouranton V, Cogne M, Lecuyer A, Leconte A, Lequesne J, Ahmed-Lecheheb D, Morel A, Fernette M, Joly F, Lange M. Virtual reality-based cognitive rehabilitation programme to support employment in patients with breast cancer: protocol for the Cog-RV pilot study. BMJ Open. 2025 Dec 15;15(12):e112196. doi: 10.1136/bmjopen-2025-112196. PMID 41401994